Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
about
11q deletion in neuroblastoma: a review of biological and clinical implications.Research progress of neuroblastoma related gene variations.Next generation mapping reveals novel large genomic rearrangements in prostate cancerBARD1 nonsense variant c.1921C>T in a patient with recurrent breast cancer.Neuroblastoma treatment in the post-genomic era.TIAM1 variants improve clinical outcome in neuroblastoma.A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway.LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors.Dualistic Role of BARD1 in Cancer.A case of neuroblastoma in DICER1 syndrome: Chance finding or noncanonical causation?miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.A highly malignant case of neuroblastoma with substantial increase of single-nucleotide variants and normal mismatch repair system: A case report.Chromatin Remodeling Proteins in Epilepsy: Lessons From CHD2-Associated Epilepsy.
P2860
Q32174267-8171D790-F446-4011-9E09-E6F1507F143EQ33566987-7438FC40-C75E-4C88-9BE2-29C987295104Q33618785-43F454EE-1616-4830-BE39-8DA74B3EEB97Q37622828-E2DAA3C9-C2C8-49DB-8CA9-675B54C2079BQ37633731-5E5ECF62-0016-4303-B1DF-CD8DCE7C2818Q38830217-A507CD96-C200-40A3-BA2C-53C144907ADAQ39649613-623CF44A-34AA-4D16-8F20-8331BF93DD07Q41345228-9BB54F6B-85D7-407C-A5DF-5DF6994C53D9Q42315795-C45F2B7F-8F94-4686-8B77-B96E3169D8BFQ47134349-3DBE6DD1-1FC2-40EA-A9DB-3C17013640FEQ47177315-F2305024-8E21-4B4D-ADEE-BE2C53653625Q47679347-F53F4B49-0317-4C20-A66C-015085732644Q47859450-C59B5E13-80D5-4B18-BA07-0AE93A4C8834Q49391301-427298B8-A5DD-4CFE-B928-AB1157BBE1ACQ49488063-BBA3F577-6840-4BDD-A81E-45F843E3EF27Q55353815-33FA0BFB-B178-42F3-82B4-6B4A9F75ACBA
P2860
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exome and deep sequencing of c ...... involved in cancer progression
@en
Exome and deep sequencing of c ...... nvolved in cancer progression.
@nl
type
label
Exome and deep sequencing of c ...... involved in cancer progression
@en
Exome and deep sequencing of c ...... nvolved in cancer progression.
@nl
prefLabel
Exome and deep sequencing of c ...... involved in cancer progression
@en
Exome and deep sequencing of c ...... nvolved in cancer progression.
@nl
P2093
P2860
P50
P356
P1433
P1476
Exome and deep sequencing of c ...... involved in cancer progression
@en
P2093
Achille Iolascon
Carlo Zanon
Carmen de Torres
Francesco Maria Calabrese
Gian Paolo Tonini
Jaume Mora
Marcella Pantile
Marilena De Mariano
Michael D Hogarty
Piero Pignataro
P2860
P304
21840-21852
P356
10.18632/ONCOTARGET.8187
P407
P50
P577
2016-04-01T00:00:00Z